
ABOUT US
A Trusted Partner for the Biopharmaceutical Industry and Laboratories
Sartorius is a leading international pharmaceutical and laboratory equipment supplier. Our customers work hard to develop and produce drugs that cure, prevent or halt the progress of diseases. To be successful in their endeavors, they rely on partners who understand their current and future challenges. For 150 years, the Sartorius brand has stood for innovative products and solutions that support the work of scientists and engineers worldwide. In doing so, we have increasingly focused on enabling breakthroughs in life science research and biomanufacturing. Sustainability, Openness, Enjoyment - these corporate values are the foundation for innovation and competitive strength at Sartorius. Our values connect us with our customers and business partners just as they do with our investors and society at large - worldwide.
Accelerating Drug Discovery and Simplifying Production
Biopharmaceuticals are produced using living cells in complex and expensive procedures. With our innovative products and services, we enable pharmaceutical researchers and lab personnel to simplify workflows, minimize human errors and speed up their work. We provide solutions that shorten the lengthy and difficult search for active ingredients. For example, new methods for cell analysis help to unlock the great potential of new therapeutic approaches, and software converts data into safe, actionable insights.
Furthermore, manufacturing technologies must also evolve to accelerate the process of taking these innovations from the lab to the clinic to increase patient access. Innovation in upstream & downstream process technologies are needed to improve the efficiency and cost of bio-manufacturing to ultimately make new promising medicines affordable.
Sartorius is part of the solution. Our technologies help simplify and accelerate biopharmaceutical process development through to commercial manufacturing. Designed with a focus on scalability, safety and robustness, we deliver end-to-end solutions and partner with manufacturers to develop optimal process designs specifically fit to their needs. In fact, Sartorius has been pioneering and setting the standards for single-use products that are currently used throughout all biopharmaceutical manufacturing processes. We help our customers to bring medications safely and quickly to the patient.
Corporate Social Responsibility
Sustainability is one of the core values firmly anchored in Sartorius’s corporate culture. It is our primary entrepreneurial responsibility to offer our customers attractive products and solutions. Innovation as well as strategic and operating excellence are the keys to accomplishing this mission. To us, sustainability means that we pursue our corporate objectives from a long-term perspective while clearly addressing social and ecological concerns. We believe that proactive administration of our social and ecological duties is not a means to compensate for our economic actions, but rather is one of the key drivers of our success.
Who we are
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions complementary technologies. In fiscal 2020, the company earned sales revenue of some 2.34 billion euros. At the end of 2020, nearly 11,000 people were employed at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
CONTACT INFORMATION
Sartorius
565 Johnson Avenue
Bohemia, NY 11716
UNITED STATES
Phone: +1.800.368.7178
Fax: 631-254-4253
HOT PRODUCTS
- BIOSTAT STR® Generation 3 Bioreactor With BIOBRAIN
- ambr® 250 Modular Bioreactor Vessel
- Single-Use Bioreactor Bag
- Virosart® Media Lab Modules
- CHO Platform Service Package For Biopharmaceutical Cell Line Development
- Recombinant Human Albumin Supporting Advanced Therapy Development
- Serum-Free, Animal Component-Free, And Protein-Free Cold Storage Solution
- Xeno-Free, Serum-Free Media For The Cultivation Of Lymphocytes
- Single-Use TFF System Configurable For ADC Synthesis
- Production Media Optimized For Viral Transfection And Infection
- CHO Media Portfolio For Protein Production Using CHO Cell Lines
- Simplify mAb Capture With A Novel Chromatography Membrane
- Cell Culture Media Services & Custom Manufacturing
- Tuflux® SIL Silicone Tubing
- Takeone® Flex Aseptic Sampling Solutions
- Water For Injection: Bulk Packaged WFI-Quality Water
- Takeone® Design Services For Aseptic Sampling Solutions
- Quickseal® Aseptic Disconnections
- Particle Validation Standards
- Mycap® Bottle Closures Aseptic Fluid Transfer System
- Robust And Consistent TPE Sealing With Biosealer® TC
- NutriFreez® D5 Salt Based Cryopreservation Solution
- Aseptic Sampling Best Practices: Sample Collection For pH And Gas Analysis
- Serum-Free, Xeno-Free Systems For Culture And Differentiation Of hMSCs
- Cell Therapy Product Characterization Services
FEATURED ARTICLES AND DOWNLOADS
- AVV Manufacturing Platform To Produce Safer Vaccines Cheaper
- Demonstrating Effective Scaling Of Rapid Cycling Chromatography
- Simplifying Large-Scale Single-Use Filtration With A Novel Modular Approach
- Take Advantage Of Single-Use Technologies For Microbial Processes
- Expand Your Capabilities With An Enhanced CLD Service Partner
- The Evolution Of A Leading Cell Line Development Technology
- Custom Solutions For Upstream Bioprocesses
- Challenges And Solutions In Aseptic Connection And Disconnection
- Solving The Analytics Bottleneck In Cell Line Development
- Break Free From The Protein A Low-Productivity Paradigm
- Overcome The Hidden Complexities Of mRNA Process Development
- A Novel Downstream Processing System For Cell Line Development Workflows
- Performance Of A Fully Automated, Single-Use TFF System In ADC Processes
- Addressing New Challenges In Bulk Drug Substance Management
- Computational Fluid Dynamics For Evaluating Cubical Mixer Performance
- How mRNA Manufacturers Disrupt The Industry
- Defining A Process For Your Unique mRNA
- Simplify Adoption With A Multi-Column Chromatography System
- Sartobind® Rapid A: High Binding Capacity At Short Residence Times
- Robust mAb Capture At High Productivity
- Proven, Scalable New Membrane Platform For mAB Capture
- Comparable High Product Quality As Protein A Resins At High Productivity
- The Journey To AAV Production In Suspension – Scaling-Up Your Process
- Expansion Of Porcine SK-RST Cells On Microcarriers Via Serial Passage In Stirred Vessels
- Development Of A Platform Approach To Binding ELISAs
- Novel Chemically Defined, Animal Component Free Medium For Vero Cells And Virus Production For Human And Animal Vaccines
- SPR Assays To The Assess Similarity Between Innovator And Biosimilar Versions of Nivolumab (Opdivo®)
- Expansion Of MRC-5 Cells On Microcarriers Via Serial Passage In Stirred Vessels
- Microcarrier Delivery System For Reduced Bioreactor Set Up Time
- Aseptic Sampling Devices In A Bioburden Reduction Strategy
- Microcarrier-Based Production Of Dengue Virus In An Optimized Animal-Free Virus Production Medium
- Expansion Of MDCK Cells On Microcarriers Via Growth In Stirred Vessels
- Large Volume Tris And DPBS Buffer Preparation
- Fast, Flexible, And Intelligent Solutions For Buffer Preparation
- Evaluation Of Influenza Production In MDCK CD Medium
- Development Of Chemically Defined Medium For Vero Cells
- Evaluation Of Signal Peptides For Enhanced Production Levels In CHO DG44 Cells
- Approaches To Establishing A Perfusion Mimic Process
- Impact Of A Chemically Defined Medium On Vero Cells Growth And Productivity
- Developing Biosimilars: Challenges And Solutions
- Expand Your Capabilities And Speed Time-to-Clinic With The Perfect Combination Of Technology And Expertise
- Advancements In Targeted mRNA Delivery
- Increased Productivity At The mAb Capture Step
- 5 Reasons To Switch To Multicolumn Chromatography
- Improving Efficiency In Cell Line Development
- The Critical Steps For Protein Therapeutic Potency Assay Development
- How A Single Provider Can Reduce Protein Biologic Development Risk
- A Multi-Scale Approach To CHO Media Benchmarking
- Improving The Overall Efficiency Of Cell Line Development
- A Look Into The Future Of Bioprocessing
- Simplify Upstream Process Intensification From PD To Manufacturing
- Combining Ambr 15 Cell Culture With Octet Titer Measurements
- Reduce Protein Biologic Development Risk
- Analytical Power Tools Open Upstream Bioprocessing Bottlenecks
- Cell Line Development: Accelerating Antibody Discovery With The Octet® Platform
- Cell Line Development Toolbox For Intensified Bioprocessing
- Cell Line Development Facts & Figures
- Comparison Of HIC Monolithic Support For Sample Displacement Chromatography Of pDNA
- Increasing Productivity Of pDNA DSP Using Sample Displacement Chromatography
- Five Ways To Accelerate Your Cell Line Development Process
- Single Cell Passaging With NutriStem® hPSC XF On Laminin-521 Without The Need For ROCK Inhibitor
- A Xeno-Free Culture System For hMSC From Various Sources Suitable For Initial Isolation And Expansion Toward Clinical Applications
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- From Cells To Organs – The Organoid Stepping-Stone
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From StemFlex™ Medium Into NutriStem® hPSC XF Medium On Matrigel®
- Efficient Transition Of Human Pluripotent Stem Cell Cultures From Essential 8™ Medium Into NutriStem® hPSC XF Medium On Vitronectin
- A Unique Defined Pre-Coating - Free Culture Platform For Isolation And Expansion Of hMSC Towards Clinical Applications
- A Guide To Accelerating Cell Line Development For Commercial Production
- Enabling Broader Adoption Of Process Intensification In Biopharma
- Qualification Summary: Shippers For Celsius® FFT | FFTp 12L With Safecore™ Technology
- In-Process Control Of pDNA Production On CIMac™ pDNA Analytical Column
- Fully Single-Use Virus Filtration In Manufacturing
- Protein A Resin Reduction With Process Transfer From Batch To BioSMB
- Extraction of mRNA From IVT Mixtures With CIMmultus® Oligo dT Column
- Purification Of mRNA By Affinity Chromatography On CIMmultus® Oligo dT Column
- N-1 Perfusion High Inoculum Fed-Batch For Reduced COGS And Easy Retrofit
- Increased Productivity With Concentrated Fed-Batch
- Optimizing Upstream And Downstream Intensification
- Intensified Seed Train Strategy For Faster, Cost-Effective Scale-Up Of Biologics Manufacturing
- Integrated Platform For Intelligent Upstream Process Intensification
- Real World Experience: Modular Facilities, Smaller Footprint With Dynamic Perfusion
- Generating A Quality Attribute Profile For Antibody-Based Biosimilars: Assessing Differences In Fc-Associated Effector Functions
- Immuno-Oncology In Vitro Assays
- Capillary Isoelectric Focusing (cIEF) As A Platform Method For The Evaluation Of Monoclonal Antibody Charge Variants
- Impact Of A Chemically Defined Medium For Vero Cells Cultivation And Virus Production For Vaccine Applications
- 4Cell®BHK-21 CD Medium - Adaptation Of BHK-21 Cells To Suspension Using Chemically Defined Medium
- A Platform Approach To Assess Lack Of Monoclonal Antibody Effector Function Using An iQue® Screener PLUS
- Development And Qualification Of A Complex Potency ELISA
- Commercial Vaccine Manufacturing - How To Prepare For Rapid Set-Up
- Rapid Transfer Of Raman Spectroscopy Models: Process Dev To Manufacturing
- Multi-Column Chromatography Process Modelling For Process Performance Prediction
- QRM For Filter Integrity Testing: Complying With EMA's Future Annex 1
- Cell Line Development Toolbox For The Development Of Intensified CHO Processes
- Low-Risk Approach For Process Transfer From Development To Manufacturing
- Save Time, Cut Costs With Process Transfer For Biologics Production
- Expediting Viral-Based Vaccines Development: Downstream Processing
- Expediting Viral-Based Vaccines Development, Part 1
- Accelerate Process Intensification For Viral Vaccine Manufacturing
- Can mRNA Disrupt The Biopharma Industry?
- Sartorius Supports The Development Of The First Vaccine Candidate Against The Novel Coronavirus To Enter Clinical Trials
- Sartorius Launches BIOSTAT STR® Generation 3 With BIOBRAIN - Making Biopharmaceutical Development And Production Faster, Simpler And Safer
- Automated Cell Bleed Control In An Intensified SU Rocking Motion Bioreactor
- Single-Use Platforms Accelerate Viral Vaccine Development, Manufacturing
- Single-Use Systems For Vaccine Manufacturing
- Integrated Tools For Upstream Process Intensification: Part II
- Integrated Tools For Upstream Process Intensification: Part I
- Sartorius Stedim Biotech Launches New Sartocheck® 5 Plus Filter Tester
- Sartorius Stedim Biotech Launches New Services For Mammalian Cell Bank Manufacturing
- Key Concepts Driving The Future Of Single-Use In Biopharma Production
- Precise Control Of Gas Flows Within The BIOSTAT B-DCU
- Automated Glucose Control
- UniVessel Single Use Bioreactor For CHO Fed-Batch Cultures
- New ambr® 250 Modular Bioreactor Vessel Launched For Cell And Gene Therapy Applications
- Biosafety Considerations For Single-Use Bioreactors
- Sartorius Stedim Biotech Introduces New SIMCA® 16 Software For Multivariate Data Analytics
- Sartorius Stedim Biotech Launches New ambr® 15 Cell Culture Microbioreactor System
- ambr ® 15 Fermentation And ambr ® 250 High Throughput Systems Now Available With Integrated Online Biomass Measurement For Microbial Applications
- 2D And 3D Pre-Designed Solutions For Storage And Shipping
- Assurance Of Quality Supply For Single-Use Pre-designed Solutions
- Ensuring Strength And Flexibility Of Single-Use Bags In All Applications
- Cell Growth Performance In Single-Use Bags
- Sartorius Joins The Community Of The National Institute For Innovation In Manufacturing Biopharmaceuticals (NIIMBL)
- Sartorius Stedim Biotech Offers Services For Characterization Of New Biological Entities (NBE)
- Sartorius Stedim Biotech Introduces BIOSTAT® RM TX With Flexsafe® RM TX For Producing Consistent Quality Cellular Products
- Sartorius Stedim Biotech And Lonza Modify Relationship For Supply Of Cell Culture Media
- Sartorius Sets Up Life Science Factory For Startup Entrepreneurs
- Aseptic Sampling Best Practices - Endotoxin Binding Affinity
- Sartorius Stedim Biotech And Siemens Sign Long-Term Cooperation Agreement In The Area Of Automation
- Sartorius Stedim Biotech And Penn State University Announce Partnership
- GMP Manufacturing Facility For Viral Vector Production
- Accelerate Process Development With High-Throughput, Single-Use, Fully Automated Bioreactors
- Advances In Single-Use Technologies For Cell Clarification
- Reducing Total Cost Of Ownership In Media Filtration
- Aseptic Sampling Product Manager On PDA Technical Report No. 69
- Sartorius Stedim Biotech Supports ABL Europe In Successful Completion Of Viral Vector GMP Capacity Expansion
- Sartorius Stedim Biotech Launches New ambr® 250 High Throughput Bioreactor System For Perfusion Culture
- Sartorius Stedim Biotech Launches New Versions Of Data Analytics Software Solutions
- Modular, Single-Use Facilities Increase Biomanufacturing Flexibility
- Sartorius Stedim Biotech Launches Chemistry Testing Services
- End-To-End, GMP Production Platform For Synthon's Biologics Pipeline
- A Unique Rapid Approach For Media And Feed Optimization
- Increase Speed To Clinic Of New Biopharmaceuticals In Upstream Processing
- Reducing Upstream Processing Scale-Up Risks Using QbD
- Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO
- Increase The Speed To Clinic Of New Biopharmaceuticals With This Approach
- Sartorius Stedim Biotech Presents First Fully Integrated Upstream Platform
- Accelerating Biopharmaceutical Development From DNA To Drug
- Sartorius Stedim Biotech Launches Innovative ambr® 250 Modular Bioreactor System
- Contamination Risk Mitigation In Cell Culture Media Preparation
- Sartorius Stedim Biotech Presents Virosart® Media
VIDEOS
- End To End Cold Chain Management Solutions
- Sensors & Data: What Feeds Effective Continuous Manufacturing?
- Q&A On Continuous Manufacturing In Biopharma
- How Do We Quantify Continuous Manufacturing Benefits?
- How Industry Orgs, Associations Are Supporting Continuous Manufacturing
- Methods To Process Intensification, Downstream Challenges In Continuous Manufacturing
- Why PAT Is Foundational To Continuous Manufacturing & What Stands In The Way
- Applications For PAT And Continuous: Seed Trains & Data Anomalies
- Can Continuous Biomanufacturing Borrow From Small Molecules?
- Who’s Ready For Continuous Manufacturing?
- Single-Use Filter Transfer Sets Ready For Final Filling
- TakeOne® Aseptic Sampling System
- Mycap® CCX Cell Culture Expansion System
- Mycap® Bottle Closures – Aseptic Fluid Transfer Systems For Bottles
- Biosealer® TC – For Sterile Disconnection Of Thermoplastic Tubing
- Upstream Process Intensification: Real-World Results
- Process Intensification: ROI Realities & Implementation Considerations
- Why Invest In Process Intensification?
- Regulatory Considerations For Process Intensification
- Supplier Qualification & Cost Of Perfusion Intensification